FINWIRES · TerminalLIVE
FINWIRES

Barry Callebaut Plunges 15% as Interim Volume Shrinks, Fiscal 2026 Profitability Outlook Weakens

-- Barry Callebaut (BARN.SW) shares dwindled 9% in early Thursday trading as fading demand, supply disruptions in North America, and a competitive overcapacity market dragged down interim sales volume and operating profit, forcing the Swiss chocolatier to downgrade its fiscal 2026 earnings guidance.

Group volume in the six months ended Feb. 28 fell 6.9% year over year to 1,010,247 tonnes due to negative market dynamics, with global chocolate volumes dropping 5.1% and those for global cocoa declining 14.3%. Ultimately, the revenue of the chocolate and cocoa products company plunged to 6.75 billion francs from 7.29 billion francs a year ago.

Operating profit or EBIT slipped 2.2% to 289.4 million francs and recurring EBIT by 5.7% to 310.9 million francs. Still, net profit attributable to Barry's shareholders surged annually to 89.4 million francs from 32.1 million francs amid lower income tax expenses. Additionally, a "significant and fast" decrease in cocoa bean prices, coupled with operational actions to reduce working capital, allowed the company to reduce net debt to 3.60 billion francs from 6.11 billion francs, which led to lower finance costs.

As Barry intends to prioritize restoring volume and leading the market back to growth, it increased its fiscal 2026 volume outlook to expect a 1% to 3% volume decline, instead of the mid-single-digit decrease projected on Jan. 21. At the same time, Barry warned about a mid-teens contraction in recurring EBIT in local currencies during the 12-month term, with the profitability outlook subject to potential impacts from disruption in the Middle East.

Previously, Barry anticipated a low- to mid-single-digit growth in recurring EBIT and a double-digit increase in recurring pretax profit in local currencies. Against this backdrop, the company noted that action was required to drive sustained profitable growth. While details will be announced in June, Barry intends to focus on key markets and segments, reintroduce a clear gourmet brand, and transition to a "smaller, more commercially focused" leadership team.

"As I reflect on my first few months at Barry Callebaut, it is clear that we have an unparalleled market position, deep expertise and fundamental growth opportunities. At the same time, we have significant work to do to reinvigorate the company after a turbulent period of industry disruption and transformation. We need to restore fundamentals, step-up service levels and empower our regional businesses," Chief Executive Officer Hein Schumacher said.

相關文章

Asia

Dizal Pharma將在美國臨床腫瘤學會年會上發表三種藥物的研究成果。

根據週三在上海證券交易所發布的公告顯示,江蘇迪扎爾製藥(SHA:688192)表示,將在美國臨床腫瘤學會(ASCO)年會上公佈其新藥sunvozertinib片劑、golidocitinib膠囊和DZD6008的最新研究成果。 sunvozertinib和DZD6008皆用於治療非小細胞肺癌,而golidocitinib則用於治療T細胞淋巴瘤。研究結果顯示,這些藥物均取得了正面成果,尤其是DZD6008,其具有顯著的抗腫瘤活性且安全性良好。 該生技公司的股價在午盤交易中上漲不到2%。

$SHA:688192
Asia

Critica將於3月季度啟動西澳大利亞稀土計畫範圍界定研究。

根據週三提交給澳洲證券交易所的文件顯示,Critica(ASX:CRI)表示,位於西澳大利亞的Jupiter稀土計畫的初步研究已於今年3月季度正式啟動。 該研究整合了選礦、下游加工、基礎設施和開發假設,旨在確定一個基準開發路徑。 公司計劃在6月季度繼續完成Jupiter專案140個鑽孔的資源升級鑽探工作。此外,該公司還計劃準備並運送20,000公斤散裝樣品進行中試規模處理,以支援持續的最佳化、性能提升和中間精礦的生產。

$ASX:CRI
Asia

北太平洋銀行的收購要約確保了對卡里爾銀行的控制權

北太平洋銀行(東京證券交易所代號:8524)週三在東京證券交易所發佈公告稱,其對Career Bank的股份收購要約已獲成功,持股比例增至88.26%,使Career Bank成為其子公司。 北太平洋銀行此次收購了852,487股Career Bank股份,超過了完成交易所需的最低收購數量。 交易結算將於4月28日開始,屆時Career Bank將正式併入北太平洋銀行的財務報表。 北太平洋銀行計劃啟動相關程序,使Career Bank成為其全資子公司,並將其股票從札幌證券交易所下市。此次收購總成本約為15億日圓。

$TYO:8524